1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2017The Kiplinger Washington Editors
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
Plenty of stocks yield more than the market average of 2% for large companies. But if you’re investing for income, you’ll want dividends that are both reliable and secure. And that’s not always...
Stocks that can deliver steady dividend growth, rather than the richest yields, offer the most fertile ground for dividend investors.
More Investing News »